Crowdonomics
All companies

Xcelerate, Inc.

Operating

Healthcare · Mauldin, SC

Estimated pre-money ⓘ
$18.2M
As of Jan 2022 · from Reg A Offering (2022) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$382,500
Across 1 round since 2022
Latest share price
$0.05
Reg A+ · Equity · Jan 2022 offering price

Financials

FY2020–FY2023 · from SEC filings · hover any figure for its source
$0
−$13K
2020
$0
−$289K
2021
$0
−$845K
2022
$1.1M
−$2.9M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2020 audited
FY2021 audited
FY2022 audited
FY2023 audited
Income statement
Revenue
$0
$0
$0
$1,122,085
Cost of goods sold
$0
—
$0
$827,968
Gross margin
—
—
—
26%
Net income
-$13,249
-$289,488
-$844,609
-$2,890,166
Balance sheet
Cash
$0
$0
$18,815
—
Accounts receivable
$0
—
—
—
Total assets
$0
$0
$228,815
—
Long-term debt
$87,901
—
—
—
Total liabilities
$19,645
$223,775
$247,199
—
Other
Headcount
0
—
—
—

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$18.2M
est. pre-money
Reg A+ · Equity · Jan 2022

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Dec 31, 2023
Series B Preferred Stock · 0.03%Common · 100.0%
ClassOutstandingVotes / shareShare of totalVotesLast price
Series B Preferred Stockpreferred120,0001,0000.03%21.6%—
Common434,446,0721100.0%78.4%$0.05Jan 2022
Total434,566,072100%100%

Shares outstanding over timein today's share terms

394M197M0
Sep 2021Dec 2023
CommonPreferred StockSeries A Preferred stockSeries B Preferred StockRound opened

Principal holders% as the filing states it, Apr 28, 2023

  • Michael F. O'Shea120,000 Series B Preferred100.0%of Series B Preferred
  • Michael F. O'Shea77,680,780 Common20.2%of
  • Clifford R. Theisen46,000,000 Common11.9%of
  • Jason Householder15,000,000 Common3.9%of
  • Steven Gravely15,000,000 Common3.9%of
  • Dr. Anja Glisovic5,000,000 Common1.3%of

Sold to the crowd

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg A+ · Equity · Jan 2022Closedvia Network 1 Financial Services Inc.
Raised $382.5K / $1MEst. pre-money $18.2M

Team

4 people
Michael F. O'Shea
Chief Executive Officer, Director
Dr. Anja Glisovic
Interim Chief Science Officer
Jason Householder
Director
Steve Gravely
Director

Names and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

  • Form 1-UMay 6, 20250001683168-25-003184
    EDGAR
  • Form 1-SASep 24, 20240001683168-24-006616
    EDGAR
  • Form 1-UMay 10, 20240001683168-24-003221
    EDGAR
  • Form 1-UMay 6, 20240001683168-24-003002
    EDGAR
  • Form 1-KApr 29, 20240001683168-24-002780
    EDGAR
  • Form 1-SASep 22, 20230001683168-23-006613
    EDGAR
  • Form 1-UJul 24, 20230001683168-23-005055
    EDGAR
  • Form 1-KApr 28, 20230001683168-23-002729
    EDGAR
Source: SEC EDGARCIK 0001138586FLShare price $0.05Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.